AMENDMENT TO SECURED CONVERTIBLE PROMISSORY NOTEConvertible Promissory Note • March 15th, 2019 • Hemispherx Biopharma Inc • Biological products, (no disgnostic substances)
Contract Type FiledMarch 15th, 2019 Company IndustryThis Amendment to Secured Convertible Promissory Note (this “Amendment”) is entered into as of March 13, 2019, by and among ILIAD RESEARCH AND TRADING, L.P., a Utah limited partnership (“Lender”), and HEMISPHERX BIOPHARMA, INC., a Delaware corporation (“Borrower”). Capitalized terms used in this Amendment without definition shall have the meanings given to them in the Note (as defined below).